AstraZeneca PLC

AstraZeneca PLC is a biopharmaceutical company that develops and commercializes prescription medicines. Its marketed products include treatments for cardiovascular, renal, metabolism, oncology, and rare diseases. The company serves physicians through distributors and local offices worldwide. It has partnerships with Neurimmune AG and BenevolentAI to develop new treatments. Founded in 1992, the company is headquartered in Cambridge, UK.

Overview

Sector

Pharmaceutical

Target Price

16.9 SEK

Current Price

1517.5 SEK

Potential

-99%

Strengths

Strong EBITDA Margin of 28.83%.

Weaknesses

With a depreciation Potential of -98.87%, based on our fundamental analysis, it suggests the stock may be overvalued.
Analysts expect revenues to decline in the coming year.

Key Financial Data

Indicator	Value
PER	32.8
EV/EBITDA	16.3
Price/Free Cash Flow'	31.7
ROIC	17.1%
Net Debt/EBITDA	1.5